STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Artivion (NYSE:AORT), a cardiac and vascular surgery company specializing in aortic disease, announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will engage in a fireside chat on September 10, 2025, at 2:35 pm ET at the Sheraton New York Times Square Hotel.

Investors can access the live webcast through Artivion's website at www.artivion.com in the Investors section. The webcast recording will remain available for 90 days following the presentation.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-0.11% News Effect

On the day this news was published, AORT declined 0.11%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ATLANTA, Sept. 5, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025, at the Sheraton New York Times Square Hotel. The Company's fireside chat is scheduled to begin at 2:35 pm ET.

A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contacts:

Artivion


Gilmartin Group LLC

Lance A. Berry


Brian Johnston / Laine Morgan

Executive Vice President,


Phone: 332-895-3222

Chief Operating Officer &


investors@artivion.com

Chief Financial Officer



Phone: 770-419-3355






Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-conference-302547997.html

SOURCE Artivion, Inc.

FAQ

When is Artivion (AORT) presenting at the Morgan Stanley Healthcare Conference 2025?

Artivion will present on Wednesday, September 10, 2025 at 2:35 pm ET at the Sheraton New York Times Square Hotel.

How can investors access Artivion's Morgan Stanley conference presentation?

Investors can access the live webcast through Artivion's website (www.artivion.com) on the Investors page. An archived recording will be available for 90 days.

What type of presentation will Artivion (AORT) give at the Morgan Stanley conference?

Artivion will participate in a fireside chat format presentation at the conference.

How long will Artivion's Morgan Stanley conference webcast be available?

The webcast recording will be available for 90 days following the presentation on Artivion's website.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.15B
43.29M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW